the WEGOVY Obesity, produced by Novo Nordisk, entered the Thai market. The local branch of the Danish manufacturer of drugs is engaged in the local advance of the popular drug.
For the first time launched in 2021, Wegovy issued Novo Nordisk to the very top of the list of Listing companies in Europe. The peak value of the structure reached $ 615 billion, writes Xrust.
The general director of the Thai daughter told reporters that the approval of Thai doctors was received in 2023. Today, the price of the product has become noticeably lower. This made it possible to begin competition with other manufacturers. The population of Thailand, we recall, about 66 million people. How attractive the other markets of this region did not open the official.
According to the general director, the Wegovy drug can be purchased according to private hospitals throughout the country, and soon it will appear in state.
- Если Вам понравилась статья, рекомендуем почитать
- Guller's goal promises the weak hopes for Real Madrid to the title
- Formula 1-Piasta selects leadership from Norris
